BLFS
BioLife Solutions Inc
36.70$
-0.4%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 51.0% | 40.9% | 41.9% | 38.8% | 31.5% | 35.9% | 49.2% | 68.9% | 38.5% | 39.3% | 34.7% | 35.4% | |
| 49.0% | 59.1% | 58.1% | 61.2% | 68.5% | 64.1% | 50.8% | 31.1% | 61.5% | 60.7% | 65.3% | 64.6% | |
| 14.1% | 21.4% | 24.7% | 10.8% | 6.6% | 15.1% | 14.0% | 9.9% | 19.4% | 8.1% | 9.6% | 7.9% | |
| 64.1% | 75.5% | 55.8% | 41.0% | 30.1% | 32.5% | 30.4% | 28.3% | 43.6% | 62.9% | 49.3% | 47.3% | |
| 99.7% | 136.9% | 117.1% | 70.8% | 50.0% | 69.9% | 57.7% | 56.8% | 69.3% | 89.3% | 73.9% | 65.4% | |
| -50.7% | -77.8% | -59.0% | -9.6% | 18.5% | -0.8% | -6.9% | -25.7% | -7.8% | -28.5% | -8.7% | -1.1% | |
| 2.9% | 0.3% | 3.9% | 1.7% | 0.0% | 0.0% | 0.0% | 0.4% | 0.9% | 2.7% | 0.9% | 2.8% | |
| -53.3% | -77.5% | -97.7% | -22.8% | 16.5% | -11.7% | -1.2% | -24.4% | -6.4% | -18.0% | -13.9% | -12.6% | |
| -1.4% | -12.8% | 19.7% | 13.2% | 2.0% | -5.6% | -6.8% | -16.9% | -6.9% | -0.1% | 0.0% | 0.1% | |
| -52.0% | -65.3% | -83.6% | -22.8% | 16.5% | -6.1% | 5.5% | -7.5% | -183.4% | -100.0% | -24.5% | -12.6% | |
| -46.5% | -72.5% | -89.4% | -6.5% | 20.3% | 9.4% | 5.1% | -14.9% | -4.1% | -10.4% | 1.9% | 3.7% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.